NCT02483182View on ClinicalTrials.gov

Safety, Tolerability and Therapeutic Efficacy of Topical ZEP-3 Ointment (1.0%) for the Treatment of Cold Sores

PHASE2CompletedINTERVENTIONAL

Enrollment

210

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

June 24, 2018

Study Completion Date

June 24, 2018

Conditions

Herpes Labialis

Interventions

DRUG

ZEP-3 ointment 1.0%

DRUG

Acyclovir cream 5%

Trial Locations (1)

Unknown

Dermatology out-patients clinic, Lev Hayasmin MC, Netanya

All Listed Sponsors

lead

Shulov Innovate for Science Ltd. 2012

INDUSTRY

NCT02483182 - Safety, Tolerability and Therapeutic Efficacy of Topical ZEP-3 Ointment (1.0%) for the Treatment of Cold Sores | Biotech Hunter | Biotech Hunter